Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
See Latest ArticlesPrimary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema: The Pan-American Collaborative Retina Study Group at 24 Months
Ophthalmology, 07/14/09
Arevalo JF et al. - Primary IVB at doses of 1.25 to 2.5 mg seem to provide stability or improvement in BCVA, OCT, and FA in DDME at 24 months. The results show no evident difference between IVB at doses of 1.25 or 2.5 mg.
Related Articles
The Course of Response To Focal/Grid Photocoagulation for Diabetic Macular Edema
Retina, 11/25/09
Relevance Score: 69%
Phacoemulsification With Intravitreal Bevacizumab Injection in Diabetic Patients With Macular Edema and Cataract
Retina, 11/20/09
Relevance Score: 68%
Pars plana vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion
European Journal of Ophthalmology, 11/13/09
Relevance Score: 68%
Is multifocal ERG a reliable index of macular function after triamcinolone acetonide injection in diffuse diabetic macular edema
European Journal of Ophthalmology, 11/11/09
Relevance Score: 68%
Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions
Retina, 11/17/09
Relevance Score: 66%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of Endophthalmitis After Intravitreal Drug Injection When Topical Antibiotics Are Not Required
Archives of Ophthalmology, 12/18/09
Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study
Acta Ophthalmologica, 12/18/09
Pre-Treatment with Intravitreal Triamcinolone Prior to Laser for Diabetic Macular Edema: 6-Month Results of a Randomised, Placebo-Controlled Trial
Investigative Ophthalmology and Visual Science, 12/18/09
Today in Retina...keeping you current
Receive free subspecialty "5-minute updates" via email
Pre-Treatment with Intravitreal Triamcinolone Prior to Laser for Diabetic Macular Edema: 6-Month Results of a Randomised, Placebo-Controlled Trial
Investigative Ophthalmology and Visual Science, 12/18/09
Adverse Events After Pars Plana Vitrectomy Among Medicare Beneficiaries
Archives of Ophthalmology, 12/18/09
Melanoma-Associated Retinopathy
Archives of Ophthalmology, 12/18/09
Article Search
Sponsor